Recently, liquid biopsy, using blood as opposed to tumor samples for molecular analysis, was developed to identify EGFR mutations with promising results.49, 50 Taking advantage of these valuable information or integrating different promising approaches may improve the performance of predicting the EGFR mutation status. Here, EGFR is linked to neoplasm.